B. Riley Issues Pessimistic Forecast for Hyperfine (NASDAQ:HYPR) Stock Price

Hyperfine (NASDAQ:HYPR) had its price target decreased by B. Riley from $1.20 to $1.00 in a research report report published on Thursday,Benzinga reports. B. Riley currently has a buy rating on the stock.

Other research analysts have also issued research reports about the company. Wells Fargo & Company dropped their price target on Hyperfine from $1.29 to $0.68 and set an “equal weight” rating for the company in a research report on Wednesday. Lake Street Capital initiated coverage on Hyperfine in a research report on Monday, March 24th. They issued a “buy” rating and a $1.50 price target for the company.

Hyperfine Stock Performance

Shares of HYPR stock opened at $0.62 on Thursday. Hyperfine has a 52-week low of $0.57 and a 52-week high of $1.90. The firm has a market capitalization of $48.36 million, a PE ratio of -1.09 and a beta of 1.04. The stock has a fifty day simple moving average of $0.74 and a two-hundred day simple moving average of $0.92.

Hyperfine (NASDAQ:HYPR) last issued its quarterly earnings data on Tuesday, May 13th. The company reported ($0.12) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.12). The firm had revenue of $2.14 million during the quarter, compared to analyst estimates of $2.82 million. Hyperfine had a negative return on equity of 57.54% and a negative net margin of 309.42%. On average, sell-side analysts forecast that Hyperfine will post -0.57 EPS for the current fiscal year.

Institutional Trading of Hyperfine

Institutional investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC lifted its stake in Hyperfine by 32.9% in the fourth quarter. Renaissance Technologies LLC now owns 212,300 shares of the company’s stock worth $187,000 after purchasing an additional 52,500 shares during the last quarter. EP Wealth Advisors LLC bought a new stake in Hyperfine in the first quarter worth about $25,000. AMH Equity Ltd bought a new stake in Hyperfine in the first quarter worth about $90,000. Wealth Enhancement Advisory Services LLC lifted its stake in Hyperfine by 64.3% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company’s stock worth $72,000 after purchasing an additional 32,093 shares during the last quarter. Finally, Virtu Financial LLC bought a new stake in Hyperfine in the fourth quarter worth about $25,000. Institutional investors own 15.03% of the company’s stock.

About Hyperfine

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.